Literature DB >> 3989521

Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.

R Morgenstern, H Fink.   

Abstract

Intra-accumbens injection of sulpiride, tiapride, and metoclopramide antagonized locomotor hyperactivity induced by intraperitoneal administration of apomorphine in rats and measured over the first five minutes after introducing the animal to an open-field cage. Sulpiride was slightly more potent than tiapride which was more than 10 times more potent than metoclopramide and haloperidol. The threshold dose of sulpiride was as low as 0.001 microgram, bilaterally. Intra-accumbens injection of sulpiride also blocked exploratory hypermotility induced by bilateral intra-accumbens injections of apomorphine and picrotoxin. The threshold dose of sulpiride for blocking these two effects was about 0.01 microgram, bilaterally. Sulpiride was more than 10 times more potent than haloperidol in blocking this apomorphine-induced hypermotility. Haloperidol did not influence the picrotoxin hypermotility. The results obtained indicate strong postsynaptic dopamine antagonist properties of sulpiride, tiapride and metoclopramide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989521     DOI: 10.1007/bf01251909

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  14 in total

1.  [Template technic for electrophysiological problems and perfusion studies in the rat].

Authors:  K Westermann; K Andreas
Journal:  Acta Biol Med Ger       Date:  1971

2.  Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.

Authors:  K S Kendler; H S Bracha; K L Davis
Journal:  Eur J Pharmacol       Date:  1982-04-23       Impact factor: 4.432

3.  Differential actions of substituted benzamides on pre- and postsynaptic dopamine receptor mechanisms in the nucleus accumbens.

Authors:  B Costall; S C Hui; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

4.  [Locomotor activity and the nucleus accumbens].

Authors:  R Morgenstern; R Gold; W Oelssner
Journal:  Biomed Biochim Acta       Date:  1983

5.  LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.

Authors:  R Morgenstern; H Fink; W Oelssner
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

Review 6.  The pharmacology of sulpiride--a dopamine receptor antagonist.

Authors:  S E O'Connor; R A Brown
Journal:  Gen Pharmacol       Date:  1982

7.  Sulpiride blocks the action of dopamine in the rat substantia nigra.

Authors:  R D Pinnock; G N Woodruff; M J Turnbull
Journal:  Eur J Pharmacol       Date:  1979-07-01       Impact factor: 4.432

8.  Differential effects of sulpiride and metoclopramide on brain. Homovanillic acid levels and shuttle box avoidance after systemic and intracerebral administration.

Authors:  Y Nishibe; Y Matsuo; T Yoshizaki; M Eigyo; T Shiomi; K Hirose
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

9.  Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.

Authors:  R Morgenstern; T Mende; R Gold; P Lemme; W Oelssner
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

10.  Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1983-05-20       Impact factor: 4.432

View more
  3 in total

Review 1.  Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.

Authors:  J W Steele; D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

2.  Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity.

Authors:  R van den Boss; A R Cools; S O Ogren
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 3.  Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.

Authors:  D H Peters; D Faulds
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.